DRKS00021813已完成不适用
Antibody assesement for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria - AK-TIR-COVID-19
Kliniken Nordoberpfalz AG0 个研究点目标入组 2,867 人开始时间: 2020年6月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,867
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Employee of Kliniken Nordoberpfalz AG or Witron Group.
- •participants >= 18 years.
- •In writing, signed and dated Informed consent after verbal Information.
排除标准
- •<18 years. Subject has not given consent for the clinical Trial.
研究者
相似试验
进行中（未招募）
不适用
Prevalence of COVID19 antibodies among blood donors.CTRI/2021/01/030455ivetha M
尚未招募
不适用
Seroprevalence of COVID-19 antibodies among patients living with hemophilia.CTRI/2022/06/043017Maulana Azad Medical College
尚未招募
不适用
Seroprevalence of COVID-19 antibodiesCTRI/2020/11/028967Kalinga Institute of Medical Sciences KIMS Regional Medical Research Center ICMR Bhubaneswar
已完成
不适用
Investigation for the prevalence of anti-SARS-CoV-2 antibody.COVID-19JPRN-UMIN000046246Fukuoka City Hospital281
招募中
不适用
Seroprevalence of anti-SARS-CoV-2 antibody in response to COVID-19 vaccine in patients with i nflammatory bowel diseaseDiseases of the digestive systemKCT0006901Keimyung University Dongsan Hospital150